Stay updated on FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial
Sign up to get notified when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.

Latest updates to the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page
- Check3 days agoChange DetectedUpdated the page to revision v3.5.0 and added a 2024 Adv Ther publication on risdiplam. The previous revision entry v3.4.3 was removed.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous v3.4.2.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedMinor revision update: Revision changed from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1. No user-facing content changes detected.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4, with no substantive changes to the study details visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check89 days agoChange DetectedAdded detailed Locations sections for multiple sites (California, Illinois, Massachusetts, New York, Rio de Janeiro, São Paulo, Lazio, Liguria, Lombardy, Moscow Oblast, Barcelona). Removed HHS Vulnerability Disclosure link and updated page revision to v3.3.3.SummaryDifference1.0%

Stay in the know with updates to FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FIREFISH: Risdiplam in Type1 SMA Infants Clinical Trial page.